富含亮氨酸重复序列激酶2基因(LRRK2)的变异体是帕金森病(PD)的危险因素,但是它们的患病率在地理上有所不同,反映创始人事件的地点和创始人后代的分散。
进行了全面的文献综述,以确定提供LRRK2十种变体中任何一种的患病率估计的研究(G2019S,R1441C,R1441G,R1441H,I2020T,N1437H,Y1699C,S1761R,G2385R,R1628P)在全球患有PD的个体中。我们计算了针对特定国家的粗略变异流行率估计值,如果可能,民族组成的调整后估计。对于基于临床的研究,先证者被用于其他家庭案件,而对于基于人群的研究,所有PD病例均使用.
该分析包括来自52个国家的161篇文章,得出了10种变体的581种患病率估计值。G2019S是最常见的变体,51个国家中有26个国家的估计值超过1.0%。其他变体不太常见。G2385R和R1628P几乎只在东亚国家观察到,他们在5-10%的病例中被发现。根据民族组成调整后的所有患病率估计值均低于未调整的患病率估计值,尽管允许这种调整的数据仅适用于六个国家。
除了G2019S,本综述涵盖的LRRK2变体在大多数研究国家并不常见.然而,一些变种的流行率较高的国家,反映了LRRK2变体的不均匀地理分布。种族群体调整后的估计值低于粗略估计值的事实表明,主要来自基于临床的研究的估计值可能夸大了某些LRRK2变体在PD中的真实患病率。
Variants in the leucine-rich repeat kinase 2 gene (LRRK2) are risk factors for Parkinson\'s disease (PD), but their prevalence varies geographically, reflecting the locations of founder events and dispersion of founders\' descendants.
A comprehensive literature review was conducted to identify studies providing prevalence estimates for any of ten variants in LRRK2 (
G2019S, R1441C, R1441G, R1441H, I2020T, N1437H, Y1699C, S1761R, G2385R, R1628P) among individuals with PD globally. We calculated crude country-specific variant prevalence estimates and, when possible, adjusted estimates for ethno-racial composition. For clinic-based studies, probands were used over other familial cases, whereas for population-based studies, all PD cases were used.
The analysis included 161 articles from 52 countries yielding 581 prevalence estimates across the ten variants.
G2019S was the most common variant, exceeding 1.0% in 26 of 51 countries with estimates. The other variants were far less common. G2385R and R1628P were observed almost exclusively in East Asian countries, where they were found in ∼5-10% of cases. All prevalence estimates adjusted for ethno-racial composition were lower than their unadjusted counterparts, although data permitting this adjustment was only available for six countries.
Except for
G2019S, the LRRK2 variants covered in this review were uncommon in most countries studied. However, there were countries with higher prevalence for some variants, reflecting the uneven geographic distribution of LRRK2 variants. The fact that ethno-racial group‒adjusted estimates were lower than crude estimates suggests that estimates derived largely from clinic-based studies may overstate the true prevalence of some LRRK2 variants in PD.